Latest Updates on Dishman Pharma
Dishman Pharma on 23rd February 2017 closed down with a loss of Rs. -4.15 (-1.81%) at Rs. 224.65. Further weakness expecting as stock closes below its support zone @ 225.
Dishman Pharma on 04th February 2017 has announced that company is declaring its Q3 results ending December 2016 on February 13, 2017 and also in this meeting they will be considering interim dividend on equity share for the financial year 2016-2017.
On 02 February 2017, Dishman Pharma opened with a gap up and closed with a gain of 2.01% @ 233.05 (+4.60) and NSE after company announced that they have received the Establishment Inspection Report (EIR) from the USFDA for its Bavla facility.
On 12 January 2017 Dishman Pharma witness selling pressure due to US President Donald Trumps remark on pricing of medicines. Stock fell down by 5.2%